The 5 most recent market catalysts affecting $JBTM, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 8, 2026
Corporate Catalyst
Neutral
Impact 65
Barclays Initiates Coverage On JBT Marel with Overweight Rating, Announces Price Target of $150
Barclays analyst Adam Seiden initiated coverage on JBT Marel (JBTM) with an Overweight rating and a $150 price target. This is a positive development for JBTM as new analyst covera…
Aug 25, 2026
Corporate Catalyst
Neutral
Impact 55
Keybanc Initiates Coverage On JBT Marel with Overweight Rating, Announces Price Target of $150
Keybanc analyst Jeffrey Hammond has initiated coverage on JBT Marel (JBTM), assigning an Overweight rating and a $150 price target. This event is significant for JBTM as new analys…
Aug 3, 2026
Corporate Catalyst
Bearish
Impact 75
JBT Marel Lowers FY2026 GAAP EPS Guidance from $4.70-$5.15 to $4.20-$4.70 vs $4.88 Est
JBT Marel announced a significant reduction in its FY2026 GAAP EPS guidance, moving from a range of $4.70-$5.15 to $4.20-$4.70. This new guidance is notably below the analyst conse…
Aug 3, 2026
Corporate Catalyst
Bearish
Impact 75
JBT Marel Lowers FY2026 Adj EPS Guidance from $8.00-$8.50 to $7.85-$8.35 vs $8.28 Est; Affirms FY2026 Sales Guidance of $3.990B-$4.065B vs $4.028B Est
JBT Marel (JBTM) has revised its FY2026 adjusted EPS guidance downwards from $8.00-$8.50 to $7.85-$8.35, falling below the analyst estimate of $8.28. This indicates a potential hea…
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 92
JBT Marel Q2 Adj. EPS $1.95 Misses $2.02 Estimate, Sales $981.000M Miss $988.467M Estimate
JBT Marel's Q2 earnings report indicates a miss on both adjusted EPS and sales estimates. While the company did achieve year-over-year growth in both metrics (30.87% increase in EP…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.